Cancer recurrence or aggravation following COVID-19 vaccination
COVID-19 infection has been a global health issue in the past recent years and numerous topics are studied in order to discover its pathophysiology and potential side effects. The potential for disease recurrence following the administration of the COVID-19 vaccine is one of the issues that has rece...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Diabetic Nephropathy Prevention
2023-06-01
|
| Series: | Journal of Nephropharmacology |
| Subjects: | |
| Online Access: | https://jnephropharmacology.com/PDF/npj-12-e10593.pdf |
| _version_ | 1797676508832071680 |
|---|---|
| author | Parisa Soleimani Sepideh Yadollahifarsani Mahsa Motieian Mahshid Sadat Chenarani Moghadam Shahrzad Alimohammadi Azadeh Khayyat Mohammad Ali Esmaeil Pour Sina Neshat Narges Alsadat Marashi Leila Mahmoodnia Rohollah Masomi |
| author_facet | Parisa Soleimani Sepideh Yadollahifarsani Mahsa Motieian Mahshid Sadat Chenarani Moghadam Shahrzad Alimohammadi Azadeh Khayyat Mohammad Ali Esmaeil Pour Sina Neshat Narges Alsadat Marashi Leila Mahmoodnia Rohollah Masomi |
| author_sort | Parisa Soleimani |
| collection | DOAJ |
| description | COVID-19 infection has been a global health issue in the past recent years and numerous topics are studied in order to discover its pathophysiology and potential side effects. The potential for disease recurrence following the administration of the COVID-19 vaccine is one of the issues that has recently attracted attention. Several studies have revealed that the COVID-19 vaccines, like other vaccines, may have side effects and, in some cases, they may even deteriorate the underlying illnesses, such as rheumatic diseases, autoimmune diseases, and cancers. The effectiveness and safety of the COVID-19 vaccine for patients with malignancies are one of the factors that are considered regarding this vaccine. Lymph node involvement, disease recurrence, and potential paraclinical changes after receiving the COVID-19 vaccine are some of the concerns of patients with malignancy. In this mini-review, we attempted to investigate cases of cancer recurrence or recovery as well as lymphadenopathy following vaccination. |
| first_indexed | 2024-03-11T22:29:13Z |
| format | Article |
| id | doaj.art-c5e56df2c5e04a3991010340c2734c0c |
| institution | Directory Open Access Journal |
| issn | 2345-4202 |
| language | English |
| last_indexed | 2024-03-11T22:29:13Z |
| publishDate | 2023-06-01 |
| publisher | Society of Diabetic Nephropathy Prevention |
| record_format | Article |
| series | Journal of Nephropharmacology |
| spelling | doaj.art-c5e56df2c5e04a3991010340c2734c0c2023-09-23T11:55:53ZengSociety of Diabetic Nephropathy PreventionJournal of Nephropharmacology2345-42022023-06-01122e10593e1059310.34172/npj.2023.10593npj-10593Cancer recurrence or aggravation following COVID-19 vaccinationParisa Soleimani0Sepideh Yadollahifarsani1Mahsa Motieian2Mahshid Sadat Chenarani Moghadam3Shahrzad Alimohammadi4Azadeh Khayyat5Mohammad Ali Esmaeil Pour6Sina Neshat7Narges Alsadat Marashi8Leila Mahmoodnia9Rohollah Masomi10Nickan Research Institute, Isfahan, IranNickan Research Institute, Isfahan, IranIndependent Researcher, Dobbs Ferry, NY, United StatesDepartment of Dermatology, Radboud University Medical Center, Nijmegen, the NetherlandsDoctoral School of Molecular Medicine, University of Debrecen, Debrecen, HungaryDepartment of Pathology, Resident Physician, Medical College of Wisconsin, Milwaukee, WI, USADepartment of Internal Medicine, Resident Physician, University of NC Health Blue Ridge, Morganton, NC, USADepartment of Pulmonology, Mayo Clinic, Jacksonville 32224 FL, USAFaculty of Life Sciences, University of Strasbourg, Strasbourg, FranceCancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, IranCancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, IranCOVID-19 infection has been a global health issue in the past recent years and numerous topics are studied in order to discover its pathophysiology and potential side effects. The potential for disease recurrence following the administration of the COVID-19 vaccine is one of the issues that has recently attracted attention. Several studies have revealed that the COVID-19 vaccines, like other vaccines, may have side effects and, in some cases, they may even deteriorate the underlying illnesses, such as rheumatic diseases, autoimmune diseases, and cancers. The effectiveness and safety of the COVID-19 vaccine for patients with malignancies are one of the factors that are considered regarding this vaccine. Lymph node involvement, disease recurrence, and potential paraclinical changes after receiving the COVID-19 vaccine are some of the concerns of patients with malignancy. In this mini-review, we attempted to investigate cases of cancer recurrence or recovery as well as lymphadenopathy following vaccination.https://jnephropharmacology.com/PDF/npj-12-e10593.pdfcancermalignancycovid-19 vaccinesars-cov-2cancer |
| spellingShingle | Parisa Soleimani Sepideh Yadollahifarsani Mahsa Motieian Mahshid Sadat Chenarani Moghadam Shahrzad Alimohammadi Azadeh Khayyat Mohammad Ali Esmaeil Pour Sina Neshat Narges Alsadat Marashi Leila Mahmoodnia Rohollah Masomi Cancer recurrence or aggravation following COVID-19 vaccination Journal of Nephropharmacology cancer malignancy covid-19 vaccine sars-cov-2 cancer |
| title | Cancer recurrence or aggravation following COVID-19 vaccination |
| title_full | Cancer recurrence or aggravation following COVID-19 vaccination |
| title_fullStr | Cancer recurrence or aggravation following COVID-19 vaccination |
| title_full_unstemmed | Cancer recurrence or aggravation following COVID-19 vaccination |
| title_short | Cancer recurrence or aggravation following COVID-19 vaccination |
| title_sort | cancer recurrence or aggravation following covid 19 vaccination |
| topic | cancer malignancy covid-19 vaccine sars-cov-2 cancer |
| url | https://jnephropharmacology.com/PDF/npj-12-e10593.pdf |
| work_keys_str_mv | AT parisasoleimani cancerrecurrenceoraggravationfollowingcovid19vaccination AT sepidehyadollahifarsani cancerrecurrenceoraggravationfollowingcovid19vaccination AT mahsamotieian cancerrecurrenceoraggravationfollowingcovid19vaccination AT mahshidsadatchenaranimoghadam cancerrecurrenceoraggravationfollowingcovid19vaccination AT shahrzadalimohammadi cancerrecurrenceoraggravationfollowingcovid19vaccination AT azadehkhayyat cancerrecurrenceoraggravationfollowingcovid19vaccination AT mohammadaliesmaeilpour cancerrecurrenceoraggravationfollowingcovid19vaccination AT sinaneshat cancerrecurrenceoraggravationfollowingcovid19vaccination AT nargesalsadatmarashi cancerrecurrenceoraggravationfollowingcovid19vaccination AT leilamahmoodnia cancerrecurrenceoraggravationfollowingcovid19vaccination AT rohollahmasomi cancerrecurrenceoraggravationfollowingcovid19vaccination |